AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI)

CUSIP: 00901B105

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
67,129,058
Total 13F shares
1,271,953
Share change
+1,271,953
Total reported value
$970,174
Price per share
$0.76
Number of holders
8
Value change
+$970,174
Number of buys
8

Quarterly Holders Quick Answers

What is CUSIP 00901B105?
CUSIP 00901B105 identifies AIMI - AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of AIMI - AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI) as of Q3 2019

As of 30 Sep 2019, AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,271,953 shares. The largest 8 holders included Anson Funds Management LP, Hudson Bay Capital Management LP, SABBY MANAGEMENT, LLC, MORGAN STANLEY, A.R.T. Advisors, LLC, BANK OF AMERICA CORP /DE/, BlackRock Inc., and American Portfolios Advisors. This page lists 8 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2019 vs Q1 2025 Across Filers

Q1 2025 holders
32
Q3 2019 holders
8
Holder diff
-24
Investor Q1 2025 Shares Q3 2019 Shares Share Diff Share Chg % Q1 2025 Value $ Q3 2019 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .